FDA

1-8 of 8 results
  • Expert Panel at ISAPP Annual Meeting Addresses Probiotic Use for Premature Infants

  • Probiotic Administration in Preterm Infants: Scientific Statement

  • EFSA’s QPS committee issues latest updates

  • The FDA’s view on the term probiotics, part 2: Further down the rabbit hole

  • The FDA’s view on the term probiotics, part 1

  • Challenges ahead in the probiotic field – insights from Probiota 2019

  • FDA/NIH Public Workshop on Science and Regulation of Live Microbiome-based Products: No Headway on Regulatory Issues

  • CBER to hold public workshop on regulation of biologics